These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7149168)

  • 1. Current status of pneumococcal polysaccharide immunization in patients with sickle cell disease or impaired splenic function.
    Ammann AJ
    Am J Pediatr Hematol Oncol; 1982; 4(3):301-6. PubMed ID: 7149168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.
    Ammann AJ; Addiego J; Wara DW; Lubin B; Smith WB; Mentzer WC
    N Engl J Med; 1977 Oct; 297(17):897-900. PubMed ID: 20575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia.
    Kaplan J; Sarnaik S; Schiffman G
    Am J Pediatr Hematol Oncol; 1986; 8(1):80-2. PubMed ID: 3717518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
    Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
    Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
    J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization.
    Overturf GD; Selzer JW; Chan L; Weiss J; Field R; Rigau-Perez JG; Powars D; Uy C; Pang EJ; Honig G; Steele R; Edmonds R; Portnoy B
    Am J Pediatr Hematol Oncol; 1982; 4(1):25-35. PubMed ID: 7091574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumococcal vaccination--yes or no?].
    Hess T
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1096-103. PubMed ID: 9691344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
    Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
    J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine.
    Ammann AJ; Schiffman G; Addiego JE; Wara WM; Wara DW
    Rev Infect Dis; 1981; 3 Suppl():S160-7. PubMed ID: 7280446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial of the protective role of polyvalent pneumococcal vaccine in sickle cell anaemia patients in Zambia.
    Chintu C; Gupta K; Osborne C; Masona JM
    Med J Zambia; 1983 Jul; 17(3):73-6. PubMed ID: 6679155
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
    Antin JH; Guinan EC; Avigan D; Soiffer RJ; Joyce RM; Martin VJ; Molrine DC
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):213-22. PubMed ID: 15744240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for pneumococcal vaccine in patients with impaired splenic function.
    Ammann AJ; Diamond LK
    N Engl J Med; 1978 Oct; 299(14):778. PubMed ID: 29221
    [No Abstract]   [Full Text] [Related]  

  • 14. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
    Siber GR; Weitzman SA; Aisenberg AC; Weinstein HJ; Schiffman G
    N Engl J Med; 1978 Aug; 299(9):442-8. PubMed ID: 28483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
    Landesman SH; Schiffman G
    Rev Infect Dis; 1981; 3 Suppl():S184-97. PubMed ID: 7025158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency.
    de Montalembert M; Lenoir G
    Ann Hematol; 2004 Jan; 83(1):18-21. PubMed ID: 14534810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to invasive bacterial infections in children with sickle cell disease.
    Battersby AJ; Knox-Macaulay HH; Carrol ED
    Pediatr Blood Cancer; 2010 Sep; 55(3):401-6. PubMed ID: 20232448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal vaccines: World Health Organization position paper.
    Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens.
    Siber GR; Weitzman SA; Aisenberg AC
    Rev Infect Dis; 1981; 3 Suppl():S144-59. PubMed ID: 7280445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyvalent pneumococcal vaccines: a review.
    Hales K; Barriere SL
    Am J Hosp Pharm; 1979 Jun; 36(6):773-7. PubMed ID: 380332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.